Canada markets open in 4 hours 28 minutes

CVS Health Corporation (CVS)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
66.85+0.88 (+1.33%)
At close: 04:00PM EDT
67.00 +0.15 (+0.22%)
Pre-Market: 04:40AM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
7,190,000
8,344,000
4,311,000
8,001,000
7,179,000
-
Depreciation & amortization
4,550,000
4,366,000
4,224,000
4,486,000
4,441,000
-
Deferred income taxes
-1,104,000
-676,000
-2,029,000
-402,000
-570,000
-
Stock based compensation
551,000
588,000
447,000
484,000
400,000
-
Change in working capital
-3,894,000
15,000
6,818,000
3,857,000
3,159,000
-
Accounts receivable
-2,658,000
-6,260,000
-2,971,000
-2,703,000
-1,510,000
-
Inventory
1,370,000
1,233,000
-1,435,000
735,000
-973,000
-
Accounts Payable
4,927,000
3,618,000
4,260,000
2,898,000
2,769,000
-
Other working capital
5,273,000
10,395,000
13,450,000
15,745,000
13,428,000
-
Other non-cash items
-
416,000
332,000
-390,000
72,000
-
Net cash provided by operating activites
8,072,000
13,426,000
16,177,000
18,265,000
15,865,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,799,000
-3,031,000
-2,727,000
-2,520,000
-2,437,000
-
Acquisitions, net
-211,000
-16,612,000
-1,388,000
-146,000
-866,000
-
Purchases of investments
-11,325,000
-9,043,000
-7,746,000
-9,963,000
-9,639,000
-
Sales/Maturities of investments
8,507,000
7,729,000
6,729,000
7,246,000
6,467,000
-
Other investing activites
96,000
68,000
85,000
122,000
-
42,000
Net cash used for investing activites
-5,732,000
-20,889,000
-5,047,000
-5,261,000
-5,534,000
-
Cash flows from financing activities
Debt repayment
-1,616,000
-8,166,000
-4,211,000
-10,254,000
-15,631,000
-
Common stock repurchased
-3,020,000
-2,012,000
-3,500,000
0
-
-
Dividends Paid
-3,256,000
-3,132,000
-2,907,000
-2,625,000
-2,624,000
-
Other financing activites
-299,000
-382,000
-449,000
-13,000
337,000
-
Net cash used privided by (used for) financing activities
-3,647,000
2,683,000
-10,516,000
-11,356,000
-7,696,000
-
Net change in cash
-1,307,000
-4,780,000
614,000
1,648,000
2,635,000
-
Cash at beginning of period
14,127,000
13,305,000
12,691,000
11,043,000
8,408,000
-
Cash at end of period
12,820,000
8,525,000
13,305,000
12,691,000
11,043,000
-
Free Cash Flow
Operating Cash Flow
8,072,000
13,426,000
16,177,000
18,265,000
15,865,000
-
Capital Expenditure
-2,799,000
-3,031,000
-2,727,000
-2,520,000
-2,437,000
-
Free Cash Flow
5,273,000
10,395,000
13,450,000
15,745,000
13,428,000
-